Dimitrios Strepkos
Athens, ESYE31 11527, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
RETRACTED: Markouli et al. Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies. Int. J. Mol. Sci. 2022, 23, 13657.
Journal: International journal of molecular sciences
Published: February 26, 2024
Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: February 10, 2023
Impact of Histone Modifications and Their Therapeutic Targeting in Hematological Malignancies.
Journal: International journal of molecular sciences
Published: September 30, 2022
Advances on Epigenetic Drugs for Pediatric Brain Tumors.
Journal: Current neuropharmacology
Published: May 17, 2022
Epigenetic mechanisms regulate sex-specific bias in disease manifestations.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: April 30, 2022
Crosstalk of Epigenetic and Metabolic Signaling Underpinning Glioblastoma Pathogenesis.
Journal: Cancers
Published: April 20, 2022
Structure, Activity and Function of the SETDB1 Protein Methyltransferase.
Journal: Life (Basel, Switzerland)
Published: July 27, 2021
Emerging roles for the YAP/TAZ transcriptional regulators in brain tumour pathology and targeting options.
Journal: Neuropathology and applied neurobiology
Published: June 01, 2021
Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis.
Journal: International journal of molecular sciences
Published: February 12, 2021
Bivalent Genes Targeting of Glioma Heterogeneity and Plasticity.
Journal: International journal of molecular sciences
Published: December 02, 2020
Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential.
Journal: Cancer research
Published: August 25, 2020
Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases.
Journal: Progress in neurobiology
Published: March 26, 2020
Last Updated: 09/26/2026